These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29342874)

  • 1. Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration.
    Ghosh Dastidar S; Warner JB; Warner DR; McClain CJ; Kirpich IA
    Biomolecules; 2018 Jan; 8(1):. PubMed ID: 29342874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a crossed high alcohol preferring (cHAP) mouse model with the NIAAA-model of chronic-binge ethanol intake to study liver injury.
    Thompson KJ; Nazari SS; Jacobs WC; Grahame NJ; McKillop IH
    Alcohol Alcohol; 2017 Nov; 52(6):629-637. PubMed ID: 29036399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse model of chronic and binge ethanol feeding (the NIAAA model).
    Bertola A; Mathews S; Ki SH; Wang H; Gao B
    Nat Protoc; 2013 Mar; 8(3):627-37. PubMed ID: 23449255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges.
    Mathews S; Xu M; Wang H; Bertola A; Gao B
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G819-23. PubMed ID: 24699333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse Model of Alcoholic Steatohepatitis.
    Bertola A
    Methods Mol Biol; 2020; 2164():145-157. PubMed ID: 32607891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.
    Zabala V; Tong M; Yu R; Ramirez T; Yalcin EB; Balbo S; Silbermann E; Deochand C; Nunez K; Hecht S; de la Monte SM
    Alcohol Alcohol; 2015 Mar; 50(2):118-31. PubMed ID: 25618784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binge ethanol and liver: new molecular developments.
    Shukla SD; Pruett SB; Szabo G; Arteel GE
    Alcohol Clin Exp Res; 2013 Apr; 37(4):550-7. PubMed ID: 23347137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury.
    Tipoe GL; Liong EC; Casey CA; Donohue TM; Eagon PK; So H; Leung TM; Fogt F; Nanji AA
    Alcohol Clin Exp Res; 2008 Apr; 32(4):669-82. PubMed ID: 18341647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice.
    Liu G; Zhang Y; Liu C; Xu D; Zhang R; Cheng Y; Pan Y; Huang C; Chen Y
    J Nutr; 2014 Jul; 144(7):1009-15. PubMed ID: 24828027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chemical Chaperone 4-Phenylbutyric Acid Prevents Alcohol-Induced Liver Injury in Obese KK-A
    Suzuki M; Kon K; Ikejima K; Arai K; Uchiyama A; Aoyama T; Yamashina S; Ueno T; Watanabe S
    Alcohol Clin Exp Res; 2019 Apr; 43(4):617-627. PubMed ID: 30748014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease.
    Kirpich IA; Feng W; Wang Y; Liu Y; Barker DF; Barve SS; McClain CJ
    Alcohol Clin Exp Res; 2012 May; 36(5):835-46. PubMed ID: 22150547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lieber-DeCarli Diet-A Flagship Model for Experimental Alcoholic Liver Disease.
    Guo F; Zheng K; Benedé-Ubieto R; Cubero FJ; Nevzorova YA
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1828-1840. PubMed ID: 30025151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury.
    Chen P; Miyamoto Y; Mazagova M; Lee KC; Eckmann L; Schnabl B
    Alcohol Clin Exp Res; 2015 Dec; 39(12):2313-23. PubMed ID: 26556636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice.
    Inamine T; Yang AM; Wang L; Lee KC; Llorente C; Schnabl B
    Alcohol Clin Exp Res; 2016 Dec; 40(12):2604-2613. PubMed ID: 27739086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Growth Factor 19 Alters Bile Acids to Induce Dysbiosis in Mice With Alcohol-Induced Liver Disease.
    Ferrell JM; Dilts M; Pokhrel S; Stahl Z; Boehme S; Wang X; Chiang JYL
    Cell Mol Gastroenterol Hepatol; 2024; 18(1):71-87. PubMed ID: 38417701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics Analysis Revealed Distinct Cyclic Changes of Metabolites Altered by Chronic Ethanol-Plus-Binge and Shp Deficiency.
    Tran M; Yang Z; Liangpunsakul S; Wang L
    Alcohol Clin Exp Res; 2016 Dec; 40(12):2548-2556. PubMed ID: 27790731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease.
    Apte UM; McRee R; Ramaiah SK
    Toxicol Pathol; 2004; 32(5):567-76. PubMed ID: 15603541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.
    Navarro M; Luhn KL; Kampov-Polevoy AB; Garbutt JC; Thiele TE
    Alcohol Clin Exp Res; 2019 May; 43(5):783-790. PubMed ID: 30817015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcoholic liver disease: Utility of animal models.
    Lamas-Paz A; Hao F; Nelson LJ; Vázquez MT; Canals S; Gómez Del Moral M; Martínez-Naves E; Nevzorova YA; Cubero FJ
    World J Gastroenterol; 2018 Dec; 24(45):5063-5075. PubMed ID: 30568384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.
    Ramadori P; Woitok MM; Estévez-Vázquez O; Benedé-Ubieto R; Leal-Lassalle H; Lamas-Paz A; Guo F; Fabre J; Otto J; Verwaayen A; Reissing J; Bruns T; Erschfeld S; Haas U; Paffen D; Nelson LJ; Vaquero J; Bañares R; Trautwein C; Cubero FJ; Liedtke C; Nevzorova YA
    Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166646. PubMed ID: 36736843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.